Song-Kyu Park

Prof. Song-Kyu Park

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2018 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
MRMd Saiful Islam Roney
Md Saiful Islam Roney
SPSong-Kyu Park
Song-Kyu Park

28 October 2023 in Viruses
Verified
Journal Article
Open access
PDF file
JLJong-Woo Lim
Jong-Woo Lim
HVHang Thi Thu Vu
Hang Thi Thu Vu
VLVan Phan Le
Van Phan Le
MYMinjoo Yeom
Minjoo Yeom
DSDaesub Song
Daesub Song
SPSong-Kyu Park
Song-Kyu Park
African swine fever (ASF) is one of the most lethal infectious diseases affecting domestic pigs and wild boars of all ages. Over a span of 100 years, ASF has continued to spread over continents and adversely affects the global pig industry. To date, no vaccine or treatment has been approved. The complex genome structure and diverse variants facilitate the immune evasion of the ASF virus (ASFV). Recently, advanced technologies have been used to design various potential vaccine candidates and effective diagnostic tools. This review updates vaccine platforms that are currently being used worldwide, with a focus on genetically modified live attenuated vaccines, including an understanding of their potential efficacy and limitations of safety and stability. Furthermore, advanced ASFV detection technologies are presented that discuss and incorporate the challenges that remain to be addressed for conventional detection methods. We also highlight a nano-bio-based system that enhances sensitivity and specificity. A combination of prophylactic vaccines and point-of-care diagnostics can help effectively control the spread of ASFV.

19 January 2012 in Oncology Reports
Verified
Journal Article
Open access
PDF file
HKHwan Mook Kim
Hwan Mook Kim
MKMoo Rim Kang
Moo Rim Kang
SPSong-Kyu Park
Song-Kyu Park
CLChang Woo Lee
Chang Woo Lee
ICIg Jun Cho
Ig Jun Cho
JKJong Soon Kang
Jong Soon Kang
Widdrol, a natural sesquiterpene present in Juniperus sp., has been shown to exert anticancer and antifungal effects. Emerging evidence has suggested that AMP-activated protein kinase (AMPK), which functions as a cellular energy sensor, is a potential therapeutic target for human cancers. In this study, we found that AMPK mediates the anticancer effects of widdrol through induction of apoptosis in HT-29 colon cancer cells. We showed that widdrol induced the phosphorylation of AMPK in a dose- and time-dependent manner. The selective AMPK inhibitor compound C abrogated the inhibitory effect of widdrol on HT-29 cell growth. In addition, we demonstrated that widdrol induced apoptosis and this was associated with the activation of caspases, including caspase‑3/7 and caspase-9, in HT-29 cells. We also demonstrated that transfection of HT-29 cells with AMPK siRNAs significantly suppressed the widdrol-mediated apoptosis and the activation of caspases. However, cell cycle arrest induced by widdrol was not affected by transfection of HT-29 cells with AMPK siRNAs. Furthermore, widdrol inhibited HT-29 tumor growth in a human tumor xenograft model. Taken together, our results suggest that the anticancer effect of widdrol may be mediated, at least in part, by induction of apoptosis via AMPK activation.

13 July 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YJYun-Ji Jeong
Yun-Ji Jeong
JKJong Soon Kang
Jong Soon Kang
SLSu In Lee
Su In Lee
DSDong Min So
Dong Min So
JYJieun Yun
Jieun Yun
SPSong-Kyu Park
Song-Kyu Park
Triple negative breast cancer (TNBC), which does not express the progesterone, estrogen, or HER2/neu receptor, is aggressive and difficult to treat. Paclitaxel, a tubulin stabilizing agent, is one of the most frequently prescribed anticancer agents for breast cancers, including TNBC. Residual disease that occurs due to resistance or partial resistance of cancer cells in a tumor against anticancer agents is the most important issue in oncology. In the present study, when MDA-MB-231 cells, a TNBC cell line, were treated with 30 µM paclitaxel, a slightly higher concentration than its GI50 value, for 6 days, a small number of cells with different morphologies survived. Among the surviving cells, small round cells were isolated, cloned, and named MDA-MB-231-JYJ cells. MDA-MB-231-JYJ cells were observed to be highly proliferative and tumorigenic. In addition, signal transduction molecules involved in proliferation, survival, malignancy, or stemness of cancer cells, such as c-Src, c-Met, Notch 1, c-Myc, Sox2, Oct3/4, Nanog, and E-cadherin were highly expressed or activated. While further study is required, MDA-MB-231-JYJ cells appear to have some of the characteristics of cancer precursor cells. Although MDA-MB-231-JYJ cells were isolated from the cells that survived in the continuous presence of paclitaxel, they were not resistant to paclitaxel but developed resistance to dasatinib, a Bcr-Abl and Src kinase family inhibitor. The activated state of Src and Notch 1, and the expression levels of c-Myc and cyclins in MDA-MB-231-JYJ cells were less affected than MDA-MB-231 cells by the treatment of dasatinib, which may explain the resistance of MDA-MB-231-JYJ cells to dasatinib. These results suggest that cancer cells that become resistant to dasatinib during the process of paclitaxel therapy in patients may appear, and caution is required in the design of clinical trials using these two agents.

8 April 2011 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
JKJong Soon Kang
Jong Soon Kang
WLWon Kyung Lee
Won Kyung Lee
WYWon Kee Yoon
Won Kee Yoon
NKNayang Kim
Nayang Kim
SPSang‐Ki Park
Sang‐Ki Park
HKHwan Mook Kim
Hwan Mook Kim

28 February 2019 in The Prostate
Verified
Journal Article
Closed access
PDF file
SLSu In Lee
Su In Lee
MRMd Saiful Islam Roney
Md Saiful Islam Roney
JPJong Hyeok Park
Jong Hyeok Park
JBJi‐Young Baek
Ji‐Young Baek
JPJooyeon Park
Jooyeon Park
SPSong-Kyu Park
Song-Kyu Park